Tags

Type your tag names separated by a space and hit enter

Antiviral, immunomodulatory, and neuroprotective effect of lithium.
J Integr Neurosci. 2022 Mar 23; 21(2):68.JI

Abstract

Currently, in psychiatry, lithium is a drug of choice as a mood stabilizer in the maintenance treatment of bipolar disorder for the prevention of manic and depressive recurrences. The second most important psychiatric use of lithium is probably increasing the efficacy of antidepressants in treatment-resistant depression. In addition to its mood-stabilizing properties, lithium exerts antisuicidal, antiviral, immunomodulatory, and neuroprotective effects. The goal of the review is to describe the experimental and clinical studies on the last three properties of lithium. Antiviral effects of lithium pertain mostly to DNA viruses, especially herpes viruses. The therapeutic effects of lithium in systemic and topical administration on labial and genital herpes were demonstrated in clinical studies. There is also some evidence, mostly in experimental studies, that lithium possesses antiviral activity against RNA viruses, including coronaviruses. The immunomodulatory effect of lithium can mitigate "low-grade inflammatory" conditions in bipolar illness. The neuroprotective properties of lithium make this ion a plausible candidate for the prevention and treatment of neurodegenerative disorders. A favorable effect of lithium was shown in experimental models of neurodegenerative disorders. On the clinical level, some preventive action against dementia and moderately therapeutic activity in Alzheimer's disease, and mild cognitive impairment were observed. Despite promising results of lithium obtained in animal models of Huntington's disease and amyotrophic lateral sclerosis, they have not been confirmed in clinical studies. A suggestion for common mechanisms of antiviral, immunomodulatory, and neuroprotective effects of lithium is advanced.

Authors+Show Affiliations

Department of Adult Psychiatry, Poznan University of Medical Sciences, 60-572 Poznan, Poland.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

35364656

Citation

Rybakowski, Janusz K.. "Antiviral, Immunomodulatory, and Neuroprotective Effect of Lithium." Journal of Integrative Neuroscience, vol. 21, no. 2, 2022, p. 68.
Rybakowski JK. Antiviral, immunomodulatory, and neuroprotective effect of lithium. J Integr Neurosci. 2022;21(2):68.
Rybakowski, J. K. (2022). Antiviral, immunomodulatory, and neuroprotective effect of lithium. Journal of Integrative Neuroscience, 21(2), 68. https://doi.org/10.31083/j.jin2102068
Rybakowski JK. Antiviral, Immunomodulatory, and Neuroprotective Effect of Lithium. J Integr Neurosci. 2022 Mar 23;21(2):68. PubMed PMID: 35364656.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Antiviral, immunomodulatory, and neuroprotective effect of lithium. A1 - Rybakowski,Janusz K, PY - 2021/2/22/received PY - 2021/3/9/revised PY - 2021/5/19/accepted PY - 2022/4/1/entrez PY - 2022/4/2/pubmed PY - 2022/4/6/medline KW - Bipolar disorder KW - Herpes virus KW - Immunomodulation KW - Lithium KW - Mood-stabilizer KW - Neuroprotection SP - 68 EP - 68 JF - Journal of integrative neuroscience JO - J Integr Neurosci VL - 21 IS - 2 N2 - Currently, in psychiatry, lithium is a drug of choice as a mood stabilizer in the maintenance treatment of bipolar disorder for the prevention of manic and depressive recurrences. The second most important psychiatric use of lithium is probably increasing the efficacy of antidepressants in treatment-resistant depression. In addition to its mood-stabilizing properties, lithium exerts antisuicidal, antiviral, immunomodulatory, and neuroprotective effects. The goal of the review is to describe the experimental and clinical studies on the last three properties of lithium. Antiviral effects of lithium pertain mostly to DNA viruses, especially herpes viruses. The therapeutic effects of lithium in systemic and topical administration on labial and genital herpes were demonstrated in clinical studies. There is also some evidence, mostly in experimental studies, that lithium possesses antiviral activity against RNA viruses, including coronaviruses. The immunomodulatory effect of lithium can mitigate "low-grade inflammatory" conditions in bipolar illness. The neuroprotective properties of lithium make this ion a plausible candidate for the prevention and treatment of neurodegenerative disorders. A favorable effect of lithium was shown in experimental models of neurodegenerative disorders. On the clinical level, some preventive action against dementia and moderately therapeutic activity in Alzheimer's disease, and mild cognitive impairment were observed. Despite promising results of lithium obtained in animal models of Huntington's disease and amyotrophic lateral sclerosis, they have not been confirmed in clinical studies. A suggestion for common mechanisms of antiviral, immunomodulatory, and neuroprotective effects of lithium is advanced. SN - 0219-6352 UR - https://www.unboundmedicine.com/medline/citation/35364656/Antiviral_immunomodulatory_and_neuroprotective_effect_of_lithium_ DB - PRIME DP - Unbound Medicine ER -